ZYUS Life Sciences Corporation ZLSCF

ZLSCF Company Overview

ZYUS Life Sciences Corporation is a Canadian life sciences and biotechnology company focused on the development and commercialization of cannabinoid-based pharmaceutical and nutraceutical products. The company operates primarily in the medical cannabis, bioscience, and drug development sectors, with an emphasis on creating standardized cannabinoid formulations intended for clinical and therapeutic use. Its activities have included cultivation, extraction, formulation development, clinical research, and intellectual property development tied to cannabinoid science.

The company’s primary revenue and development focus has centered on medical cannabis products, cannabinoid-derived compounds, and research collaborations involving human health applications. ZYUS has positioned itself around pharmaceutical-grade cannabinoid production and evidence-based product development, differentiating itself from recreational cannabis-focused operators. The company evolved from earlier cannabis-sector operations and reoriented toward life sciences and clinical development initiatives as the broader Canadian cannabis industry matured and became more competitive.